Carter Bankshares, Inc. (CARE)
NASDAQFinancialsBanks - RegionalSnapshot 2026-09-09
$31.40+0.13%
Close 2026-09-09 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-09-09
Warn: Management is running behind on a stated commitment.
Carter Bankshares has improved interest income by about $4.2 million annually through portfolio repositioning. Earnings grew strongly, with net income rising from $5.4 million to $85.8 million and EPS from $0.24 to $3.88 recently. The company maintains a $10 million share repurchase program and pays a quarterly dividend of $0.10 per share. These show solid financial strength and shareholder returns.
Revenue is expected to decline nearly 10% next year, which could pressure earnings. The company faces litigation risks and volatile management. If earnings weaken or the portfolio repositioning fails to improve income, the outlook dims.
The price is about 18% above our fair value estimate near $27. Analysts expect about 10% revenue decline. Our view is more optimistic on earnings and portfolio income improvement than the market consensus.
Breaks if: repurchase program is canceled or materially delayed
Execute share repurchase program authorized for up to $10 million over twelve months to return capital to shareholders.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on maintaining strong earnings. The current thesis state is intact, supported by recent financial results, but management's volatility adds an element of uncertainty.
The market appears to have priced in a low expectations gap, suggesting that current valuations are justified. The stock is considered cheap compared to peers, but there is a premium of 1.05, indicating some investor confidence.
Fundamentals are likely to remain strong in the near term, as management has successfully increased net interest income and maintained a consistent dividend. However, there is a moderate risk due to management's mixed execution on strategic priorities.
The thesis hinges on the performance of sector bellwethers like HDB, IBN, and PNC. Positive earnings from these companies could support CARE, while any guidance cuts or misses could negatively impact sentiment.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that would weaken the thesis.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: dividend cut or suspension
Breaks if: net income or EPS falls below 90% of target levels
Sustain and grow earnings through margin expansion, loan growth, and credit quality management.
Stated in 2 of last 2 quarters. Net interest income grew from $35.9 million in 2026-Q1 to $40.0 million in 2026-Q2, with net interest margin expanding from 3.07% to 3.38%. Total portfolio loans increased by $6.1 million in 2026-Q2 despite significant loan payoffs. These financial results demonstrate delivering on management's priority to maintain strong earnings performance.
“Core operating performance remained strong with net interest margin expansion and loan portfolio growth.”
“Delivered strong operating performance highlighted by margin expansion and solid loan growth across footprint.”
Breaks if: interest income improvement falls below $4 million annually
Continue strategic repositioning of available-for-sale securities to improve asset yields and balance sheet positioning.
Stated in 2 of last 2 quarters. The company sold $139.4 million and purchased $88.5 million in securities with higher yields in 2026-Q2, expecting to improve interest income by approximately $4.2 million annually. This strategic repositioning aligns with management's stated goal to enhance asset yields and balance sheet positioning, indicating delivering progress.
“Completed a strategic repositioning of a portion of its available-for-sale securities portfolio resulting in a pre-tax loss of $12.5 million.”
“Announced strategic repositioning of a portion of its securities portfolio to improve interest income by approximately $4.2 million annually.”
Overall, CARE's financial health is solid, but management's volatility and external sector factors are key risks to monitor. Not investment advice.